[Minimal residual disease in leukemia]
- PMID: 1888177
[Minimal residual disease in leukemia]
Abstract
Recently, detection of the minimal residual disease (MRD) has become possible by polymerase chain reaction (PCR) using leukemia specific DNA or mRNA sequences originated from t(9; 22), t(1; 19) and t(14; 18) translocations, T cell receptor or immunoglobulin CDRIII. This method made possible to detect one leukemic cell out of 10(4)-10(5) cells, and the presence of MDR became clear during complete remission after chemotherapy or bone marrow transplantation. This suggests the usefulness of this method in the treatment of leukemia.
Similar articles
-
[Detection of minimal residual disease using reverse transcriptase polymerase chain reaction technique].Nihon Rinsho. 1992 Jun;50(6):1380-5. Nihon Rinsho. 1992. PMID: 1381448 Japanese.
-
Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.Am J Hematol. 1996 Jul;52(3):171-7. doi: 10.1002/(SICI)1096-8652(199607)52:3<171::AID-AJH6>3.0.CO;2-Q. Am J Hematol. 1996. PMID: 8756082
-
Detection of minimal residual disease using clonospecific primers for CDRIII in patients with acute B lymphocytic leukemia with or without Philadelphia chromosome: possibility of clinical application as a tool for improving prognosis.Exp Hematol. 1994 Aug;22(9):881-7. Exp Hematol. 1994. PMID: 8062887
-
[The detection of minimal residual disease in leukemia by in vitro DNA amplification].Rinsho Byori. 1991 Dec;39(12):1298-307. Rinsho Byori. 1991. PMID: 1779467 Review. Japanese.
-
[Detection of minimal residual leukemia using polymerase chain reaction method].Rinsho Byori. 1996 Jun;44(6):535-40. Rinsho Byori. 1996. PMID: 8752731 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials